Cytarabine
Common brands: Methotrexate, Trexall, Jylamvo, Otrexup, Rasuvo
Top reporter: Fresenius Kabi Usa, Llc
Nucleoside Metabolic Inhibitor [EPC]Corticosteroid [EPC]Alkylating Drug [EPC]Folate Analog Metabolic Inhibitor [EPC]Topoisomerase Inhibitor [EPC]
58,625
Total Reports
31,834
Serious Reports
13,474
Death Reports
30
Reported Reactions
Death Report Ratio: High (22.98%)
Patient Demographics
Reported Adverse Reactions (30)
Side effects reported in FDA adverse event reports for Cytarabine.
| # | Reaction | Reports | % of Total |
|---|---|---|---|
| 1 | FEBRILE NEUTROPENIA | 7,495 | |
| 2 | OFF LABEL USE | 4,977 | |
| 3 | PYREXIA | 4,090 | |
| 4 | NEUTROPENIA | 3,636 | |
| 5 | DRUG INEFFECTIVE | 3,109 | |
| 6 | SEPSIS | 2,922 | |
| 7 | THROMBOCYTOPENIA | 2,897 | |
| 8 | DISEASE PROGRESSION | 2,732 | |
| 9 | PNEUMONIA | 2,301 | |
| 10 | MYELOSUPPRESSION | 2,088 | |
| 11 | PANCYTOPENIA | 2,085 | |
| 12 | DEATH | 2,027 | |
| 13 | SEPTIC SHOCK | 1,852 | |
| 14 | NAUSEA | 1,833 | |
| 15 | INFECTION | 1,817 | |
| 16 | ANAEMIA | 1,805 | |
| 17 | DIARRHOEA | 1,759 | |
| 18 | PRODUCT USE IN UNAPPROVED INDICATION | 1,755 | |
| 19 | MUCOSAL INFLAMMATION | 1,718 | |
| 20 | VOMITING | 1,715 | |
| 21 | PLATELET COUNT DECREASED | 1,637 | |
| 22 | HYPOTENSION | 1,464 | |
| 23 | ACUTE MYELOID LEUKAEMIA | 1,308 | |
| 24 | WHITE BLOOD CELL COUNT DECREASED | 1,251 | |
| 25 | RESPIRATORY FAILURE | 1,246 | |
| 26 | BONE MARROW FAILURE | 1,217 | |
| 27 | ACUTE KIDNEY INJURY | 1,212 | |
| 28 | HEADACHE | 1,042 | |
| 29 | ABDOMINAL PAIN | 1,002 | |
| 30 | NEUTROPHIL COUNT DECREASED | 961 |
Important Disclaimer
FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.